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Uterine NK cells are innate lymphoid cells (ILC) that populate the uterus and expand 
during pregnancy, regulating placental development and fetal growth in humans and 
mice. We have recently characterized the composition of uterine ILCs (uILCs), some of 
which require the transcription factor NFIL3, but the extent to which NFIL3-dependent 
cells support successful reproduction in mice is unknown. By mating Nfil3−/− females 
with wild-type males, here we show the effects of NFIL3 deficiency in maternal cells on 
both the changes in uILCs during pregnancy and the downstream consequences on 
reproduction. Despite the presence of CD49a+Eomes− uILC1s and the considerable 
expansion of residual CD49a+Eomes+ tissue-resident NK cells and uILC3s in pregnant 
Nfil3−/− mice, we found incomplete remodeling of uterine arteries and decidua, placental 
defects, and fetal growth restriction in litters of normal size. These results show that 
maternal NFIL3 mediates non-redundant functions in mouse reproduction.
Keywords: mouse models, uterine nK cells, placenta, pregnancy, lymphocyte subpopulations
inTrODUcTiOn
Human and murine uterine NK cells (uNK) are innate lymphoid cells (ILCs) that produce factors 
active on both uterine arteries and fetal placental cells (1–3), contributing to successful reproduction 
(4–6). The role of uNK in pregnancy may have coevolved with that of variable immune system genes 
in reproduction (7, 8). We and others have recently shown that various ILC groups are present in 
both human and mouse uterus and, similar to ILCs in other tissues, uterine ILCs (uILCs) may also 
play roles in pregnancy (9, 10). For example, IFN-γ produced by uNK cells is the key factor required 
for uterine vascular adaptation during murine pregnancy (11), and various other ILC populations 
produce IFN-γ, including conventional (cNK) and tissue-resident NK cells (trNK), uterus and liver 
ILC1s, and gut NCR+ ILC3s (12). On the other hand, other cytokines produced by uILCs may affect 
TaBle 1 | numbers of uterine cD49a+ and cD49a− nK cells in WT and Nfil3−/− mice.
spleen (×106) V. uterus (×104) Myometrium (×104) Decidua (×104)
WT mice
NK1.1+ NKp46+ 1.613 ± 0.139 2.345 ± 0.358 11.9 ± 0.07 1.84 ± 0.031
cNK 1.515 ± 0.131 0.809 ± 0.206 2.215 ± 0.127 0.768 ± 0.070
CD49a+ 0.098 ± 0.027 1.536 ± 0.293 9.581 ± 0.582 1.071 ± 0.229
Nfil3−/− mice
NK1.1+ NKp46+ 0.035 ± 0.023* 0.879 ± 0.044 1.932 ± 0.01*** 0.459 ± 0.007**
cNK 0.019 ± 0.009* 0.057 ± 0.026* 0.030 ± 0.014*** 0.012 ± 0.004***
CD49a+ 0.008 ± 0.029* 0.816 ± 0.005 1.932 ± 0.763*** 0.447 ± 0.053*
Leukocytes were enriched from virgin (v. uterus) and pregnant (gd9–10.5) uteri (myometrium separated from decidua) and stained for CD45, NK1.1, NKp46, CD3, DX5, and 
CD49a. Conventional NK cells (cNK) are identified as CD49a−DX5+. Based on percentages of positive cells, absolute cell numbers were calculated out of total live singlet CD45+ 
lymphocytes. Statistically significant differences between WT and Nfil3−/− for each subset are indicated (*P < 0.05; **P < 0.01; ***P < 0.001, unpaired t-test, n = 2–5 independent 
experiments).
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pregnancy and reproduction, e.g., IL-5 produced by uILC2s and 
IL-17 and IL-22 produced by uILC3s (9, 10). Indeed, mice lacking 
lymphocytes, including uILCs, show impaired uterine arterial 
modifications (11) and fetal growth restriction (13). Defective 
uterine vascular remodeling and shallow trophoblast invasion 
are associated with great obstetrical syndromes, including 
preeclampsia and fetal growth restriction (14), and unbalanced 
cytokine production may lead to preterm labor (15).
Mice lacking the basic leucine zipper transcription factor 
NFIL3/E4BP4 display immune abnormalities (16), including 
severely reduced numbers of cNK cells (17) as well as reduced ILCs 
in several tissues (18–21). NFIL3 also regulates the emergence of 
common ILC precursors (22). However, the requirement for NFIL3 
during development, homeostasis, and function of different ILCs is 
lineage and tissue specific. Indeed, Nfil3−/− mice retain trNK cells in 
uterus, liver, salivary glands, and skin, as well as thymically derived 
NK cells (23–25), and we have shown that they also have uILC3s 
(9). Moreover, the few residual cNK cells in Nfil3−/− mice exhibit 
normal effector functions in response to mouse cytomegalovirus 
infection (26). How the absence of NFIL3 impacts maternal 
responses to the endocrine and immunological changes occurring 
during gestation is unknown. We have begun to answer these 
questions by describing the changes in uILCs during pregnancy in 
Nfil3−/− mice mated with wild-type (WT) males. Using these mice, 
here we show that absence of maternal NFIL3 lead to a dramatic 
reduction of cNK cells and uILC2s during pregnancy. Despite the 
expansion of residual CD49+Eomes+ trNK cells and uILC3s and the 
presence of abundant CD49+Eomes− uILC1s at midgestation, the 
uterine vasculature in Nfil3−/− females failed to complete the vascu-
lar remodeling process necessary to ensure ample and steady blood 
supply to the fetoplacental unit. This was associated with placental 
abnormalities and reduced fetal growth, although litter sizes were 
normal. The results demonstrate that NFIL3 regulates important 
functions for reproduction in mice, including key aspects of uILCs.
resUlTs anD DiscUssiOn
curtailed expansion of nfil3−/− unK cells 
in response to Pregnancy
We asked if the residual uNK in virgin Nfil3−/− females require 
NFIL3 to expand at midgestation. To do this, we quantified 
CD3−NK1.1+NKp46+ uNK numbers in both virgin and pregnant 
Nfil3−/− females and compared them with numbers in WT 
females. Both Nfil3−/− and WT females were mated with WT 
males to restrict NFIL3 deficiency to maternal tissues. Pregnant 
uteri were dissected into decidua  –  which is the transformed 
mucosa that forms in response to blastocyst implantation in 
mice  –  and the muscular outer layer, the myometrium, which 
includes a transient lymphoid structure that forms in rodents 
during pregnancy, the mesometrial lymphoid aggregate of 
pregnancy (MLAp). CD3−NK1.1+NKp46+ uNK expanded from 
2.3 × 104 cells in virgin to 13.7 × 104 cells in pregnant WT mice 
(5.9-fold increase). The expansion in Nfil3−/− mice was less 
pronounced, from 0.9 × 104 cells in virgin to 2.4 × 104 cells in 
pregnant mice (2.7-fold increase). Most of this expansion in both 
WT and Nfil3−/− dams was due to accumulation of uNK cells in 
the myometrium (Table 1).
Based on the expression of the two integrins CD49a 
(ITGA1, VLA-1) and DX5 (CD49b, ITGA-2, VLA-2), uterine 
CD3−NK1.1+NKp46+ cells can be divided in two subsets: 
CD49a+DX5− and CD49a−DX5+ cells, which resemble similar sub-
sets in liver trNK and cNK cells, respectively (25). Figure 1A shows 
a representative flow cytometry analysis, Figure 1B a diagrammatic 
representation, and Table 1 summarizes the quantification of the 
expansion of the two subsets during pregnancy. The expression of 
CD49a and DX5 has been described as mutually exclusive on the 
two subsets both in liver and uterus (25); however, we found that 
DX5 was expressed on most uterine CD49a+ cells. In Nfil3−/− mice, 
the expression of DX5 on many CD49a+ cells increased at midg-
estation, albeit less than on cNK cells in WT mice (Figure 1A). 
NFIL3 may regulate expression of integrins (27), and we found that 
in Nfil3−/− dams, expression of DX5 on some of the CD49a+ cells 
became even higher than that on cNK cells (Figure 1A).
Ex vivo, both CD49a+ cells and cNK cells stained positive 
for Ki-67, a marker strictly associated with cell proliferation 
(Figure 1C). Given the considerable expansion and the lower rate 
of proliferation in decidual cNK cells in WT mice (Figures 1A,C), 
it is conceivable that some of decidual cNK cells are cNK cells 
that came from the periphery. Another possible explanation is the 
in situ generation from progenitors, and both scenarios remain to 
be tested. Like the hepatic CD49a+ cells, also uterine CD49a+ cells 
were CD69+ and CD62L− (Figure 1C).
FigUre 1 | reduced expansion of unK cells in Nfil3−/− dams. (a) Representative flow cytometry plots showing separation of CD45+CD3−NK1.1+NKp46+ NK 
cells in CD49a+ uNK and CD49a−DX5+ (cNK) cells in the indicated tissues in WT and Nfil3−/− females. (B) Visual representation of composition and expansion of 
CD49a+ uNK (blue) and CD49a−DX5+ cNK (red) in the uterus of virgin and pregnant WT and Nfil3−/− mice. (c) Representative flow cytometry histograms of 
intracellular Ki-67, surface CD69 and CD62L in ex vivo CD49a+ uNK, and CD49a−DX5+ cNK in the indicated tissues of WT females. Data representative of two to 
three independent experiments, n = 4–20 mice per group.
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Phenotyping Uterine cD49a+ and  
cD49a− cells
Expression of Eomes, among ILCs, defines NK lineages, whereas 
high granularity and staining with the lectin Dolichos biflorus 
agglutinin (DBA) in mice are features associated with uNK cells. 
We analyzed Eomes expression, granularity, and DBA reactivity 
on the two subsets of CD49a+ and CD49a+ uterine cells gated on 
CD45+CD3−CD19−NK1.1+NKp46+ cells. All CD49a− cNK and 
most CD49a+ cells expressed Eomes in WT mice (Figure 2A), 
thus marking them as “bona fide” NK cells. The minority of the 
CD49a+ cells that did not express Eomes are Eomes− uILC1s (9). 
uNK have also been known as “granulated” cells in several spe-
cies (28). The granularity of CD49a+ cells was more pronounced 
than that of cNK cells (Figure 2A). Perhaps the most distinctive 
feature of mouse uNK cells is the positivity for DBA staining (29), 
although more recently, it has become apparent that some uNK 
cells are not reactive for DBA (30, 31), may be the largest producer 
of IFN-γ (32) and, if inhibited, contribute to insufficient uterine 
FigUre 2 | Uterine ilcs in virgin and pregnant Nfil3−/− mice. (a) Representative flow cytometry histograms of intracellular Eomes, granularity (SSC), size (FSC), 
and reactivity for Dolichos biflorus agglutinin (DBA) lectin (GMFI is indicated) in ex vivo CD49a+ NK and CD49a− cNK in the indicated tissues of WT females. The 
negative control cell population for DBA reactivity is made up of CD3+ and CD19+ cells. (B) Representative immunofluorescence stainings of gd9.5 implantation sites 
(decidua) from WT and Nfil3−/− pregnant females mated with WT males. Almost all DBA+ uNK (red) express intranuclear Eomes (green), as indicated by arrowheads. 
Scale bar = 50 μm. (c) Absolute numbers and composition in group 1 ILCs in the uterus from WT and Nfil3−/− virgin and pregnant females (left graph). 
Representative flow cytometry plots of the changes in group 1 ILC composition from virgin to pregnant Nfil3−/− mice (right panel). Gated on 
CD45+CD3−CD19−NK1.1+NKp46+ cells, uILC1 are defined as CD49a+Eomes−, uterine trNK cells as CD49a+Eomes+, and cNK cells as CD49a−Eomes+. Data 
representative of two to five independent experiments. (D) Absolute numbers and composition in uILC2s and uILC3s in the uterus from WT and Nfil3−/− virgin and 
pregnant females (left graph). Representative flow cytometry plots of the changes in uILC2 and uILC3 composition from virgin to pregnant Nfil3−/− mice (right panel). 
GATA-3hiST2+ uILC2s are gated on CD45+CD3−CD19−CD11b−NK1.1−NKp46−CD90.2+ cells. RORγt+CD127+ uILC3s are gated on 
CD45+CD3−CD19−CD11b−NK1.1−CD90.2+ cells. Data representative of two to three independent experiments.
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adaptations to pregnancy (13). DBA staining mostly colocalized 
with Eomes staining in tissue sections of both WT and Nfil3−/− 
dams (Figure  2B). Although both CD49a+ cells and cNK cells 
stained positive for DBA, CD49a+ cells showed a brighter staining 
than cNK cells (Figure 2A), suggesting that these cells may relate 
more closely to what traditionally has been referred to as a major 
subset of uNK cells. In line with this, CD49a+ cells produced less 
IFN-γ than cNK cells after stimulation with PMA and ionomycin 
or with IL-12 and IL-15 (not shown).
expansion of group 1 Uterine ilc1 
subsets in Pregnancy
The data here and those in the accompanying manuscript 
(33) corroborate our recently published data, which show that 
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Eomes expression defines two populations of group 1 ILCs 
within the CD49a+ subsets, which, along with cNK cells make 
up the three subsets of group 1 uILC1, defined collectively 
as CD45+CD3−CD19−NK1.1+NKp46+ cells (9). The three 
subsets are CD49a+Eomes+ trNKs, CD49a+Eomes− ILC1s, and 
CD49a−DX5+ cNK cells (9). We next set out to define how 
pregnancy and the lack of NFIL3 affect the changes in these 
three subsets of group 1 ILC1s. Eomes+ trNK cells expanded 
about sevenfold in Nfil3−/− mice (Figure  2C). This expansion 
was nearly as extensive as in pregnant WT mice; however, trNK 
cells were still over fivefold less numerous in Nfil3−/− dams than 
in WT dams, presumably because they were already decreased 
in virgin mice. Eomes− uILC1s did not seem to expand in 
Nfil3−/− dams and expanded very little in pregnant WT dams 
too. CD49−DX5+ cNK cells did not expand at all in Nfil3−/− dams, 
whereas they expanded 3.7-fold in WT dams (Figures 1A and 
2C; Table 1). These results show that the population of uterine 
group 1 ILC that expand the most during pregnancy in WT 
mice is trNK cells, with some expansion of cNK cells and little 
or no expansion of Eomes− uILC1 cells (Figure 2C; Table 1). 
NFIL3 is required for development and expansion of uterine 
cNK cells and for development of trNK cells, but is dispen-
sable for the expansion of trNK cells and the development of 
Eomes− uILC1s.
expansion of Uterine ilc2 and ilc3 in 
Pregnancy
NFIL3 is important also for the development of other ILCs. 
Nfil3−/− mice are severely deficient in ILCs in several tissues, such 
as the intestine or the lungs (19–21). Recently, we have shown that 
only uILC2s strictly require NFIL3 to develop in the uterus of vir-
gin mice (9). Indeed, uILC2s were not detectable in virgin Nfil3−/− 
mice and barely detectable in pregnant Nfil3−/− mice (Figure 2D), 
and uILC3s were present in virgin Nfil3−/− mice but they did not 
expand as in WT mice during pregnancy (Figure 2C).
It will be interesting to study the potential role of uILC2s and 
uILC3s during murine pregnancy, for example, in MLAp forma-
tion. Moreover, ILC3s are the most abundant non-NK ILCs in 
the human uterus (9, 10), and they may play roles in human 
pregnancy.
Altogether, the data show that NFIL3 may serve different roles 
in different uILC lineages. Homeostatic development of trNK in 
virgin mice, but not expansion in response to pregnancy, requires 
NFIL3, whereas the opposite seems to be true for uILC3s. On the 
other hand, cNK and uILC2s require NFIL3 for both develop-
ment and expansion.
Maternal, Placental, and Fetal 
abnormalities in nfil3−/− Dams
Our data show that Nfil3−/− mice exhibit defects in the develop-
ment and/or the expansion of uterine cNK cells and other uILCs 
during pregnancy. The residual trNK cells, as well as the Eomes− 
uILC1s and the uILC3s found in Nfil3−/− dams, may however 
sustain the uterine adaptations necessary for placentation and 
fetal growth. In order to test this, we compared uterine arterial 
changes, litter sizes, and placental and fetal growth in WT and 
Nfil3−/− dams mated with syngeneic WT mice. In contrast to what 
was found in allogeneic pregnancies (34), we found normal litter 
sizes. Therefore, the lack of NFIL3 does not impact on the number 
of live births in our crosses. Previous work with mice that do not 
develop uNK cells or have hypofunctional uNK cells showed that 
these mice too have normal litter sizes. However, analysis of uter-
ine tissues and fetoplacental growth revealed clinically relevant 
abnormalities in these mice (11, 13).
To assess the role of residual ILCs in Nfil3−/− mice during preg-
nancy, we used stereology and immunohistochemistry to analyze 
morphological aspects of implantation sites in Nfil3−/− females 
mated with WT males. DBA+ uNK cells were readily detected 
in uterine sections of both WT and Nfil3−/− mice, including in 
the decidua and in the MLAp (Figures  3A,B). The MLAp is 
reduced in size in NK-deficient mice (11) or in mice engineered 
to have hypofunctional uNK cells (13), and we found here that 
it was also the case in Nfil3−/− dams (Figures  3A,B). Vascular 
walls were thicker with incomplete loss of smooth muscle actin 
(SMA) in Nfil3−/− dams (Figures 3B,C), a phenotype typical of 
NK-deficient mice (11, 13). Impaired arterial remodeling in 
uNK-deficient mice results in placental abnormalities and fetal 
growth restriction. Nfil3−/− dams and their fetuses displayed 
phenotypes similar to those of NK-deficient mice (Figure 4A). 
Conversely, WT females mated with Nfil3−/− males had normal-
sized fetuses and placentas (Figure  4B). The comparison of 
Nfil3−/+ with Nfil3+/− conceptuses showed that the reduction in 
fetal weight and the increase in placental weight is a phenotype 
of maternal origin (Figure 4C).
The labyrinth zone of mouse placenta is analogous to the 
human placental villi, where nutrient and gaseous exchange take 
place. The volume of the labyrinth zone was larger in placentas of 
Nfil3−/− dams (Figures 4D,E). Trophoblast and maternal blood 
spaces, as well as the thickness of the barrier separating the fetal 
and maternal blood spaces, were increased in placentas of Nfil3−/− 
dams (Figure 4E). These abnormalities, with the exception of the 
surface area of placental exchange, mirror those in NK-deficient 
Rag2−/−Il2rg−/− dams (Figure 4F) and are consistent with altered 
placental hemodynamics secondary to deficient spiral artery 
remodeling (35, 36). The reason and the significance of the 
divergent phenotype of the surface area of placental exchange 
in Nfil3−/− and Rag2−/−Il2rg−/− dams are unclear; however, it may 
reflect the difference in cellularity in the two strains, with residual 
ILCs and other lymphocytes in Nfil3−/− dams and total lack of all 
lymphoid cells in Rag2−/−Il2rg−/− dams.
In a mouse model of allogeneic pregnancy, Fu et  al. found 
increased Th17 cells in the decidua of Nfil3−/− dams, which was 
associated with fetal demise, and they suggested that the absence 
of uNK cells in Nfil3−/− dams might have caused Th17 expansion 
and breakdown of tolerance (34). We find here that some NK 
are instead present in Nfil3−/− dams at midgestation, alongside 
Eomes− uILC1s, and uILC3s. In conclusion, our results show that 
the residual uILCs in Nfil3−/− dams are not sufficient to mediate 
normal uterine adaptations to pregnancy. Placentation and fetal 
growth is compromised in the absence of NFIL3, which emerges 
as an essential mediator of non-redundant functions for 
reproduction in mice.
FigUre 3 | abnormalities in uterine tissues of Nfil3−/− dams. (a) Representative immunohistological staining of gd9.5 implantation sites from WT and 
Nfil3−/− pregnant females mated with WT males. DBA+ uNK cells (brown) within the mesometrial lymphoid aggregate of pregnancy (MLAp) and the decidua and in 
proximity of the invading trophoblast, which is stained with cytokeratin (purple). Bar = 500 μm. (B) H&E and immunohistological staining of MLAp and decidua at 
higher magnification showing MLAp area, distribution of uNK around vessels, and presence of residual smooth muscle actin (SMA) within the vascular wall. 
Bar = 500 μm. Indicated is the maternal geotype. All females were mated with WT males. (c) Stereological quantification of MLAp (left), vascular lumen area 
(middle), and relative wall thickness (right). Means ± SEM of data representative of 4–6 litters per genotype. Statistical differences were calculated with an unpaired 
Student’s t-test.
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MaTerials anD MeThODs
Mice
C57BL/6J mice were purchased from Charles River UK and were 
used as WT mice in all experiments. Nfil3−/− and Rag2−/−IL2rg−/− 
mice were in C57BL/6J background as previously described (17, 
37). All mating experiments used virgin females mated either with 
C57BL/6J males or with Nfil3−/− males as indicated. Gestation 
day (gd) 0.5 was counted at noon of day of the appearance of a 
copulation plug. Virgin and pregnant females were age matched 
(7–12 weeks). All procedures were conducted in accordance with 
the University of Cambridge Animal Welfare and Ethical Review 
Body and United Kingdom Home Office Regulations.
cell Preparation
Ovaries, mesometrium, and cervix were removed from all uteri 
in ice-cold PBS without Ca2+/Mg2+. Virgin uteri were entirely 
minced with scissors. For gd9.5 and gd10.5 mid-gestated uteri, 
myometrium tissue (including MLAp) were first dissected from 
the decidua and pooled. The decidua basalis (containing placenta) 
tissues were also separately minced and pooled. Embryos, yolk 
sacs, and decidua parietalis were discarded. Minced tissues 
were first softened in the predigestion solution, 1× HBSS (PAA) 
containing 5 mM EDTA (Sigma), 15 mM HEPES solution (Life 
Technologies), and 10% FCS (Life Technologies) under moderate 
rotation (220 rpm) for 2 × 15 min at 37°C. Then, the cell suspen-
sion was filtrated through a 100-μm cell strainer and the minced 
tissues were rinsed from remaining EDTA with 1× PBS. This 
flow-through fraction containing intraepithelial lymphocytes is 
stored on ice by the time the minced tissue undergoes enzymatic 
digestion. The latter are dissociated in RPMI 1640 containing 2% 
FCS, 0.1 WU/ml Liberase DH, and 30 μg/ml DNase (Roche) for 
30 min at 37°C under gentle agitation. Digested tissues were fully 
dissociated with a syringe plunger against a 100-μm cell strainer. 
Pre-digest and post-digest flow-through solutions were pooled 
and washed in Ca2+/Mg2+-free PBS containing 5 mM EDTA for 
enzyme inactivation. The cell suspension was overlayed on a 
80/40% Percoll (GE Healthcare Life Sciences) gradient and the 
FigUre 4 | Fetal and placental abnormalities in Nfil3−/− dams. (a) Fetal weight, placental weight, and ratio of fetal/placental weight of conceptuses from either 
WT or Nfil3−/− females mated with WT males. Means ± SEM of data representative of 3–18 litters per maternal genotype per gestational age. (B) Fetal and placental 
weights of conceptuses from WT females mated either with WT or Nfil3−/− males. Means ± SEM of data representative of 4–5 litters per maternal genotype. (c) Fetal 
and placental weight of heterozygous offspring from either Nfil3−/− dams (a) or Nfil3−/− fathers (B). Means ± SEM of data representative of 4–5 litters per cross. 
(a–c) Statistical differences were calculated using mixed effect modeling taking into account the clustering of pups from the same litter. (D) Representative H&E 
staining of gd18.5 placenta from WT and Nfil3−/− dams. The discontinuous line demarcates the labyrinth zone (Lz). (e,F) Stereological evaluation of the volume of 
labyrinth zone, maternal blood space, trophoblast, barrier thickness, and surface area of exchange in placentas from Nfil3−/− dams (e) and in placentas from 
lymphocyte deficient Rag2−/−Il2rg−/− dams (F), both compared to those from WT dams. Data representative of 5–11 placentas per genotype for Lz volume and 4–9 
placentas for Lz structure (MBS, trophoblast, BT, and SA). Statistical differences were calculated with an unpaired Student’s t-test.
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leukocyte fraction was collected at the interface. Cells from spleens 
and livers (from virgin mice) were similarly prepared except from 
the EDTA pre-digest step [adapted from Ref. (38, 39)].
Flow cytometry
Conjugated Abs anti-mouse CD45 (clone 30-F11), CD3ϵ (500A2 
or 17A2), CD19 (6D5), NK1.1 (PK136), NKp46 (29A1.4), CD90.2 
(30-H12), ST2 (RMST2-2), CD49b (DX5), NK1.1 (PK136), NKp46 
(29A1.4), CD62L (MEL-14), CD127 (A7R34), RORγt (Q31-378), 
anti-human/mouse CD11b (M1/70), Eomes (Dan11mag) and 
CD16/32-Fc blocking (93), anti-rat/mouse CD49a (Ha31/8), anti-
human/mouse GATA-3 (TWAJ and 16E10A23), and Ki-67 (B56) 
were purchased from Biolegend, eBioscience, BD Biosciences, 
or R&D Systems. Transcription factors and Ki-67 were stained 
using the FoxP3 staining buffer set (eBioscience) according to the 
manufacturer’s instructions. Fixable viability dyes eFluor 780 and 
eFluor 506 (eBioscience) was used to exclude dead cells. Cells were 
stained with DBA (Vector Labs) after the fixation/permeabilization 
step. Samples were acquired on a LSR Fortessa (BD Biosciences) 
using FACS DiVa and analyzed using FlowJo (Tree Star).
immunohistochemistry
Total pregnant uteri were fixed 6  h at room temperature (RT) 
in formalin and embedded in paraffin. Sections were serially 
cut at 7 μm and stained with hematoxylin and eosin (H&E) at 
49  μm intervals using standard methods. For chromogenic 
IHC cytokeratin/DBA double staining, proteinase-K mediated 
antigen retrieval was performed, and sections were incubated 
with polyclonal rabbit anti-cytokeratin (1:1000, DAKO, Z0633) 
at 4°C, followed with biotinylated universal pan-specific anti-
body (1:500, Vector lab, BA-1300) for 1  h at RT and labeled 
using VECTASTAIN ABC-AP KIT (Vector lab, AK-5000) and 
SIGMA Fast (Sigma-Aldrich, F4523). After colorimetric detec-
tion, sections were blocked using Avidin/Biotin Kit (Vector lab, 
SP-2001) and incubated with biotinylated DBA-lectin (6.6 μg/ml) 
for 30  min at RT, labeled using ABC kit (Vector lab, PK6100) 
and DAB, Diaminobenzidine (Sigma-Aldrich, D4168). For SMA, 
SMA single staining, paraffin sections were subjected to citrate 
buffer heat-induced epitope retrieval (HIER) for 3 min, blocked 
using Mouse On Mouse (MOM) kit (Vector lab, MKB-2213), and 
incubated with mouse anti-human SMA (1:100, DAKO, M0851) 
for 30 min at RT, followed by MOM biotinylated anti-mouse IgG 
reagent (Vector lab, MKB-2213), labeled using ABC kit (Vector 
lab, PK6100) and DAB (Sigma-Aldrich, D4168) and counter-
stained with hematoxylin. All immunohistochemical stainings 
included isotype controls. For dual immunofluorescence staining 
of DBA and Eomes, 7 μm thick cryosections of uterine tissue at 
gd9.5 were fixed in 100% acetone at 4°C for 20 min. Sections were 
incubated with AF488-conjugated rat anti-mouse Eomes (eBio-
science, Dan11mag, 1:50) for 60 min at RT and sequentially with 
FITC-conjugated donkey anti-rat IgG (Jackson Immunoresearch, 
712-095-153, 1:150), AF488-conjugated rabbit anti-fluorescein/
Oregon Green (Life Technologies, A-11090, 1:200), and AF488-
conjugated donkey anti-rabbit IgG (Life Technologies, A-21206, 
1:100) for 30  min each at RT. Sections were incubated with 
6.6 μg/ml biotinylated DBA and labeled using AF555-conjugated 
streptavidin (Life Technologies, S-32355, 1:500), each for 30 min 
at RT. Sections were counterstained with DAPI. Images were 
acquired using a Leica SP5 confocal microscope and analyzed 
using ImageJ software to adjust brightness and contrast.
stereology analysis of Mlap Volume and 
Decidual arteries
Tissue volumes were quantified from serial sections using the 
Cavalieri method (40). Briefly, MLAp cross-sectional areas were 
calculated on serial sections and volumes were calculated by 
accounting for the spacing between the sections as previously 
described (41). Arterial remodeling was evaluated in the central 
decidua basalis on sagittal sections and veins localized at the 
periphery were excluded. Three to five implantation sites from 
randomly chosen uterine horn were analyzed per litter. In every 
implantation site, three to five largest vessels were measured in 
triplicate (three sections with distance of 49 μm apart). Lumen 
area and vessel-to-lumen ratios were quantitated by using out-
lines tools from NDP viewer (Hamamatsu) and Aperio ePathol-
ogy (Leica Biosystems) softwares. SMA IHC staining was used for 
further qualitative assessment of arterial remodeling (41).
stereology analysis of Placentas
Midsagittal cross-sections of placental tissue (gd18.5) were stained 
with H&E using standard protocols. From each of nine WT and 
five Nfil3−/− mice, the placenta closest in weight to the litter mean 
was selected for stereology analysis. The fractional volumes of 
the labyrinth zone (Lz) were assessed by point counting (10× 
objective lens, the newCAST Computer Assisted Stereological 
Toolbox system Visopharm, Hoersholm, Denmark) with system-
atic random sampling (42). Assuming a density of 1 mg mm−3, 
fractional volumes were converted to absolute volumes in cubic 
millimeter by multiplying by total placental volume (43). The 
other placental halves were fixed in glutaraldehyde and embed-
ded in Spurr’s epoxy resin and a single mid-line section taken 
(1 μm thickness) then stained with toluidine blue. Volumes of 
maternal blood space and trophoblast in the Lz, surface area, and 
thickness of the barrier were calculated at 100× magnification 
using stereological methods that were described previously (42).
statistics
Data were analyzed using paired or unpaired parametric Student’s 
t-test or non-parametric Mann–Whitney test. Fetal and placental 
weights were analyzed using a mixed model approach to test the 
effect of maternal genotype and account for both gestational age 
and clustering of observations by litter (44). P < 0.05 was taken 
as statistically significant for all tests. Analyses were performed 
using GraphPad Prism and IBM SPSS.
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